Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection

Int J Biol Macromol. 2020 Aug 1:156:928-937. doi: 10.1016/j.ijbiomac.2020.04.048. Epub 2020 Apr 11.

Abstract

DNA vaccine is an important tool to elicit both humoral and cellular immunity. Present study investigates mucosal immune response of Labeo rohita (15 ± 04 g) to plasmid DNA (pDNA) vaccine macromolecule complexed with nanoparticles (NPs). Poly lactic-co-glycolic acid (PLGA), Chitosan (Chit) and PLGA-Chit-NPs were synthesized by double emulsion solvent evaporation method. Synthesized NPs were complexed with pDNA (pGPD + IFN) vaccine construct. Size and zeta potential of PLGA-NPs, Chit-NPs and PLGA-Chit-NPs-pDNA complex were recorded to be 120 nm and +0.5 mV, 117 nm and +32 mV, 189 nm and +11 mV, respectively. Immunization by immersion was carried out in two groups receiving PLGA-Chit-NPs-pDNA (T1) and PLGA-NPs-pDNA (T2) respectively. After immersion, samples were collected on 0, 2, 4, 7, 15 and 30 days from mucosa-associated lymphoid tissues (MALT) for mRNA expression studies of IgM, IgD and IgZ using qRT-PCR. Significant up-regulation of the mRNA expression of IgM, IgD, and IgT were observed in MALT in immunized fish compared to control. After 30 days post-immunization fish were infected with a virulent strain of Edwardsiella tarda. The highest relative percentage survival was observed in T1 (64.7%) compared to T2. The study showed better efficiency of pDNA-PLGA-Chit-NPs compared to pDNA-PLGA-NPs for inducing adaptive mucosal immunity in fish.

Keywords: Bicistronic DNA vaccine; Edwardsiella tarda; Labeo rohita; Mucosal immunity; Poly lactic-co-glycolic acid-chitosan nanoparticles.

MeSH terms

  • Animals
  • Chitosan / chemistry*
  • Edwardsiella tarda / immunology*
  • Fish Diseases / prevention & control*
  • Fishes
  • Immunity, Mucosal*
  • Immunization
  • Immunogenicity, Vaccine
  • Nanoparticles / chemistry*
  • Polylactic Acid-Polyglycolic Acid Copolymer / chemistry*
  • Spectrum Analysis
  • Treatment Outcome
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology*

Substances

  • Vaccines, DNA
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Chitosan